News
Nivo/ipi combo now ‘standard of care’ in mesothelioma
After 3 years, 23% of patients who received combination immunotherapy were still alive, in comparison with 15% of patients in the chemotherapy arm...
News
Adjuvant pembro success in early melanoma raises questions
“How come all get treated? What about the risks of toxicity? The costs? And where do we fit these patients into clinic?”
News
‘Urgent’ need to understand immunotherapy de-escalation in NSCLC
In addition to a toxicity and quality-of-life, immunotherapy de-escalation could have a significant impact on the costs of care.
News
Tackling grief, loss in patients with advanced lung cancer
Most palliative care centers report insufficient capacity to meet the demand.
News
ESMO 2021: Impressive clinical research despite pandemic
ESMO will be held online September 16-21. Among findings to be reported include the results of immunotherapy trials for melanoma.
News
Researchers warn young adults are at highest risk of obesity
Adults aged 18-24 years gained the most weight over 10 years compared with older individuals and should be a key target for prevention programs,...
News
POSEIDON: Two ICIs plus chemo up survival in mNSCLC
Adding durvalumab to chemotherapy significantly improved progression free survival by 26% but did not significantly improve overall survival.
News
Antibiotic use and colon cancer: More evidence of link
The data “strengthen prior evidence and provide new insights into site-specific carcinogenesis as well as indirect support for the role of gut...
News
Air pollution – second leading cause of lung cancer
“As lung cancer professionals, we can mitigate the effects of air pollution on causing lung cancer by speaking out for clean energy standards.”
News
Antibiotic linked to rise in early onset colon cancer?
“We now want to find out if there is a link between antibiotic use and changes in the microbiome which can make the colon more susceptible to...